文献速递免疫规划卫生政策与健康促进

印度常规免疫规划成本的决定因素

Determinants of cost of routine immunization programme in India.
PubMed 文献 · Vaccine · 2018-01-01

研究基于印度全国代表性的次中心和初级卫生保健中心样本,分别纳入99家和89家机构,采用多水平回归模型分析机构免疫服务成本的决定因素。结果显示,机构成本与接种总剂次、机构类型、主要接种人员工资、免疫服务次数及机构与最近冷链点的距离显著相关;州使用五价疫苗是含疫苗成本总成本的重要决定因素。

要点

  • 机构免疫成本与接种总剂次、机构类型、主要接种人员工资、免疫服务次数及距最近冷链点距离显著相关。
  • 州使用五价疫苗是含疫苗成本总成本的重要决定因素。
  • 印度正引入多种新疫苗,政府需确保全球疫苗免疫联盟支持停止后额外资源到位。

核心结论

  • 机构免疫成本与接种总剂次、机构类型、主要接种人员工资、免疫服务次数及机构与最近冷链点的距离显著相关。
  • 州使用五价疫苗是含疫苗成本总成本的重要决定因素。
  • 印度正引入多种新疫苗,政府需确保全球疫苗免疫联盟支持停止后额外资源到位。

研究设计与样本

  • 基于印度全国代表性样本的次中心和初级卫生保健中心(分别为99家和89家机构)的机构成本分析。
  • 采用多水平回归模型,纳入州和地区级随机效应,以考虑多阶段抽样设计。
  • 对机构总成本(分别含和不含疫苗成本)取对数后与多个解释变量进行回归。

主要发现

  • 机构成本与接种总剂次、机构类型、主要接种人员工资、免疫服务次数及机构与最近冷链点的距离显著相关。
  • 州使用五价疫苗是含疫苗成本总成本的重要决定因素。

关键数值与推荐

  • 机构成本与接种总剂次、机构类型、主要接种人员工资、免疫服务次数及机构与最近冷链点的距离显著相关。
  • 州使用五价疫苗是含疫苗成本总成本的重要决定因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The costs of delivering routine immunization services in India vary widely across facilities, districts and states. Understanding the factors influencing this cost variation could help predict future immunization costs and suggest approaches for improving the efficiency of service provision. We examined determinants of facility cost for immunization services based on a nationally representative sample of sub-centres and primary health centres (99 and 89 facilities, respectively) by regressing logged total facility costs, both including and excluding vaccine cost, against several explanatory variables. We used a multi-level regression model to account for the multi-stage sampling design, including state- and district-levelrandom effects. We found that facility costs were significantly associated with total doses administered, type of facility, salary of the main vaccinator, number of immunization sessions, and the distance of the facility from the nearest cold chain point. Use of pentavalent vaccine by the state was an important determinant of total facility cost including vaccine cost. India is introducing several new vaccines including some supported by Gavi. Therefore, the government will have to ensure that additional resources will be made available after the support from Gavi ceases.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Chatterjee S, Ghosh A, Das P, et al. Determinants of cost of routine immunization programme in India. Vaccine. 2018. PMID: 29776749. doi:10.1016/j.vaccine.2018.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。